Structure Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GPCR and other ETFs, options, and stocks.About GPCR
Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its pipeline includes Aleniglipron GSBR-1290, ACCG-2671, GIPR, GCGR, ANPA-0073, and LTSE-2578.
CEORaymond C. Stevens
CEORaymond C. Stevens
Employees163
Employees163
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2016
Founded2016
Employees163
Employees163
GPCR Key Statistics
Market cap2.14B
Market cap2.14B
Price-Earnings ratio-9.66
Price-Earnings ratio-9.66
Dividend yield—
Dividend yield—
Average volume1.55M
Average volume1.55M
High today$35.62
High today$35.62
Low today$33.41
Low today$33.41
Open price$34.06
Open price$34.06
Volume685.38K
Volume685.38K
52 Week high$40.29
52 Week high$40.29
52 Week low$13.22
52 Week low$13.22
Stock Snapshot
As of today, Structure Therapeutics(GPCR) shares are valued at $35.04. The company's market cap stands at 2.14B, with a P/E ratio of -9.66.
On 2025-11-24, Structure Therapeutics(GPCR) stock traded between a low of $33.41 and a high of $35.62. Shares are currently priced at $35.04, which is +4.9% above the low and -1.6% below the high.
Structure Therapeutics(GPCR) shares are trading with a volume of 685.38K, against a daily average of 1.55M.
In the last year, Structure Therapeutics(GPCR) shares hit a 52-week high of $40.29 and a 52-week low of $13.22.
In the last year, Structure Therapeutics(GPCR) shares hit a 52-week high of $40.29 and a 52-week low of $13.22.
Analyst ratings
100%
of 14 ratingsBuy
100%
Hold
0%
Sell
0%